NO314400B1 - Substituerte tricykliske forbindelser - Google Patents

Substituerte tricykliske forbindelser Download PDF

Info

Publication number
NO314400B1
NO314400B1 NO19991821A NO991821A NO314400B1 NO 314400 B1 NO314400 B1 NO 314400B1 NO 19991821 A NO19991821 A NO 19991821A NO 991821 A NO991821 A NO 991821A NO 314400 B1 NO314400 B1 NO 314400B1
Authority
NO
Norway
Prior art keywords
methyl
hydroxy
oxyacetic acid
carbamoyl
benzyl
Prior art date
Application number
NO19991821A
Other languages
English (en)
Norwegian (no)
Other versions
NO991821L (no
NO991821D0 (no
Inventor
Benjamin Alan Anderson
Nicholas James Bach
Jolie Anne Bastian
Nancy Kay Harn
Richard Waltz Harper
Gary Alan Hite
Michael Dean Kinnick
Ho-Shen Lin
Richard James Loncharich
Iii John Mcneill Mcgill
Edward David Mihelich
Jr John Michael Morin
Michael Leroy Phillips
Michael Enrico Richett
Daniel Jon Sall
Jason Scott Sawyer
Richard Walter Schevitz
Robert Theodore Vasileff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991821D0 publication Critical patent/NO991821D0/no
Publication of NO991821L publication Critical patent/NO991821L/no
Publication of NO314400B1 publication Critical patent/NO314400B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19991821A 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser NO314400B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6232898A 1998-04-17 1998-04-17

Publications (3)

Publication Number Publication Date
NO991821D0 NO991821D0 (no) 1999-04-16
NO991821L NO991821L (no) 1999-10-18
NO314400B1 true NO314400B1 (no) 2003-03-17

Family

ID=22041763

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19991821A NO314400B1 (no) 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser
NO19991822A NO312240B1 (no) 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser, preparater inneholdende forbindelsene samt forbindelsenes anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19991822A NO312240B1 (no) 1998-04-17 1999-04-16 Substituerte tricykliske forbindelser, preparater inneholdende forbindelsene samt forbindelsenes anvendelse

Country Status (30)

Country Link
EP (2) EP0950657B1 (es)
JP (2) JPH11322713A (es)
KR (2) KR19990083232A (es)
CN (1) CN1149193C (es)
AR (2) AR018186A1 (es)
AT (2) ATE268756T1 (es)
AU (2) AU753436B2 (es)
BR (2) BR9902365A (es)
CA (2) CA2269246C (es)
CO (2) CO5011054A1 (es)
CZ (2) CZ136999A3 (es)
DE (2) DE69918590T2 (es)
DK (1) DK0950657T3 (es)
DZ (1) DZ2769A1 (es)
EA (2) EA002347B1 (es)
ES (2) ES2222663T3 (es)
HU (2) HUP9901221A3 (es)
ID (2) ID23761A (es)
IL (2) IL129485A0 (es)
NO (2) NO314400B1 (es)
NZ (3) NZ335253A (es)
PE (2) PE20000476A1 (es)
PL (2) PL332565A1 (es)
PT (1) PT950657E (es)
SG (2) SG81977A1 (es)
SI (1) SI0950657T1 (es)
TR (2) TR199900843A2 (es)
TW (1) TWI238160B (es)
YU (2) YU19199A (es)
ZA (2) ZA992772B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009978A1 (en) * 1997-08-28 1999-03-04 Eli Lilly And Company Method for treatment of non-rheumatoid athritis
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
CA2358492A1 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
EP1202963B1 (en) * 1999-07-19 2007-01-03 Eli Lilly And Company Spla2 inhibitors
WO2002000256A1 (en) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
ATE375171T1 (de) * 2000-06-29 2007-10-15 Anthera Pharmaceuticals Inc Heilmittel für krebs
US20040102442A1 (en) * 2000-06-29 2004-05-27 Kohji Hanasaki Remedies for alzheimer's disease
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
EP1345898A2 (en) 2000-12-18 2003-09-24 Eli Lilly And Company Teracyclic carbazole derivates and their use as spla2 inhibitors
ATE353876T1 (de) 2001-03-28 2007-03-15 Lilly Co Eli Substituierte carbazole als inhibitoren von spla2
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
DE10249055A1 (de) 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituierte-1,3-diketone
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1988098A1 (en) * 2007-04-27 2008-11-05 AEterna Zentaris GmbH Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
WO2009119534A1 (ja) 2008-03-26 2009-10-01 第一三共株式会社 新規テトラヒドロイソキノリン誘導体
JP5637982B2 (ja) 2008-04-09 2014-12-10 インフィニティー ファーマシューティカルズ, インコーポレイテッド 脂肪酸アミド加水分解酵素の阻害剤
WO2010084402A2 (en) * 2009-01-22 2010-07-29 Orchid Research Laboratories Ltd. Heterocyclic compounds as phosphodiesterase inhibitors
CA2757622A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
BR112012019120A2 (pt) 2010-02-03 2016-06-28 Infinity Pharmaceuticais Inc forma sólida, composição farmacêutica, método de preparação do composto 1, método de tratamento de uma condição mediada por faah
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CN102816107B (zh) * 2012-08-20 2015-06-03 东南大学 咔唑衍生物及其制备方法与用途
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных
MX2015006864A (es) 2012-11-30 2015-09-16 Ge Healthcare Ltd Proceso de ciclizacion mediado con haluro de cinc que conduce a indoles triciclicos.
WO2016116527A1 (de) * 2015-01-20 2016-07-28 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
CN108707104A (zh) * 2018-08-07 2018-10-26 北京恒信卓元科技有限公司 2-氯-1h-咔唑-1,4(9h)-二酮的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
CA2110514A1 (en) * 1991-07-05 1993-01-21 Raymond Baker Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles
BR9612347A (pt) * 1995-12-13 1999-07-13 Lilly Co Eli Naftil acetamidas como inibidores de spla2
PL332896A1 (en) * 1996-10-30 1999-10-25 Lilly Co Eli Substituted tricyclic compounds
WO1999016453A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
JP2001522884A (ja) * 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.

Also Published As

Publication number Publication date
TR199900843A2 (xx) 2000-02-21
CN1253948A (zh) 2000-05-24
NZ335253A (en) 2000-11-24
HU9901221A (hu) 2000-04-28
PE20000432A1 (es) 2000-05-23
SI0950657T1 (en) 2005-02-28
AU753436B2 (en) 2002-10-17
DE69917833D1 (de) 2004-07-15
DE69918590D1 (de) 2004-08-19
NO312240B1 (no) 2002-04-15
SG81976A1 (en) 2001-07-24
CA2269246C (en) 2009-08-25
DE69917833T2 (de) 2005-07-14
DE69918590T2 (de) 2005-07-21
NO991821L (no) 1999-10-18
ATE271037T1 (de) 2004-07-15
SG81977A1 (en) 2001-07-24
HUP9901221A3 (en) 2001-11-28
BR9902365A (pt) 2001-04-24
KR100586761B1 (ko) 2006-06-08
PE20000476A1 (es) 2000-06-02
AR018593A1 (es) 2001-11-28
CA2269262A1 (en) 1999-10-17
PL332566A1 (en) 1999-10-25
CZ137099A3 (cs) 1999-11-17
DZ2769A1 (fr) 2003-12-01
EA002816B1 (ru) 2002-10-31
BR9901279A (pt) 2000-05-02
EP0950657A3 (en) 2001-08-16
YU19199A (sh) 2002-08-12
ES2226286T3 (es) 2005-03-16
IL129483A0 (en) 2000-02-29
AR018186A1 (es) 2001-10-31
EP0952149A3 (en) 2001-08-16
PL332565A1 (en) 1999-10-25
ID23761A (id) 2000-05-11
ID23287A (id) 2000-04-05
ES2222663T3 (es) 2005-02-01
JP4435330B2 (ja) 2010-03-17
NO991822D0 (no) 1999-04-16
DK0950657T3 (da) 2004-11-22
HU9901221D0 (en) 1999-06-28
TR199900853A3 (tr) 1999-11-22
NO991822L (no) 1999-10-18
IL129485A0 (en) 2000-02-29
ZA992771B (en) 2002-04-18
EA199900301A3 (ru) 2000-04-24
EP0950657B1 (en) 2004-07-14
EP0952149A2 (en) 1999-10-27
AU2381999A (en) 1999-10-28
JP2000026416A (ja) 2000-01-25
ZA992772B (en) 2002-07-16
KR19990083232A (ko) 1999-11-25
EA002347B1 (ru) 2002-04-25
KR19990083233A (ko) 1999-11-25
YU18999A (sh) 2002-08-12
CZ136999A3 (cs) 1999-11-17
EP0950657A2 (en) 1999-10-20
PT950657E (pt) 2004-11-30
NZ507564A (en) 2002-10-25
AU2381799A (en) 1999-10-28
TR199900853A2 (xx) 1999-11-22
CA2269246A1 (en) 1999-10-17
NZ335251A (en) 2000-11-24
CO5011054A1 (es) 2001-02-28
CO5031247A1 (es) 2001-04-27
AU753547B2 (en) 2002-10-24
ATE268756T1 (de) 2004-06-15
EA199900303A3 (ru) 2000-04-24
HU9901220D0 (en) 1999-06-28
JPH11322713A (ja) 1999-11-24
NO991821D0 (no) 1999-04-16
CN1149193C (zh) 2004-05-12
HUP9901220A3 (en) 2001-11-28
TWI238160B (en) 2005-08-21
EA199900303A2 (ru) 1999-10-28
HU9901220A (hu) 2000-04-28
EA199900301A2 (ru) 1999-10-28
EP0952149B1 (en) 2004-06-09

Similar Documents

Publication Publication Date Title
NO314400B1 (no) Substituerte tricykliske forbindelser
EP0772592B1 (en) 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS
AU2009247262B2 (en) Amide compound
US6177440B1 (en) Substituted tricyclics
US8969561B2 (en) Apixaban preparation process
US5684034A (en) 1H-indole-3-acetamide sPLA2 inhibitors
JP3241381B2 (ja) 三環性キノキサリンジオン化合物
NO177139B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater
NO314899B1 (no) Substituerte tricykliske forbindelser samt preparater inneholdende forbindelsene
JP2001503055A5 (es)
EP0950661B1 (en) Substituted tricyclics useful in sPLA2 induced diseases
US20050026988A1 (en) Cyclopenta'b! indole derivatives as spla inhibitors
US6713645B1 (en) Substituted tricyclics
DE60208065T2 (de) Cyclohept'b! indolderivate als spla2-inhibitoren
JP3162572B2 (ja) インドロイルグアニジン誘導体
JP2004518659A5 (es)
EP1395554B1 (en) Substituted carbazoles as inhibitors of spla2
JPH0533701B2 (es)
NO175680B (no) Fremgangsmåte for fremstilling av en 3-alkylert indol
NO165798B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-disubstituerte 2-oksindol-derivater.
MXPA99003587A (es) Compuestos triciclicos substituidos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees